Article
Designing and engineering of a site-specific incorporation of a keto group in uricase.
Chemical biology & drug design - 1 Sept 2011
Fang Zhengzhi, Liu Yaguang, Liu Jingxian, Sun Renhua, Chen Hai, Gao Xiangdong, Yao Wenbing
Abstract excerpt
Urate oxidase is a potential therapeutic protein in the prevention and treatment of tumor lysis syndrome and hyperuricemia. However, its severe immunogenicity limits its clinical application. In our work, several strides have been made toward engineering site-specific modifications of keto groups in urate oxidase by using evolved Methanocaldococcus jannaschii aminoacyl-tRNA synthetase(s)/suppressor tRNA pairs to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
